Eli Lilly and Company (NYSE:LLY) Q3 2023 Earnings Call Transcript

Eli Lilly and Company (NYSE:LLY) Q3 2023 Earnings Call Transcript November 2, 2023 Eli Lilly and Company beats earnings expectations. Reported EPS is $0.1, expectations were $-0.11. Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q3 2023 Earnings Call. At this time all participants are in a listen-only mode […]

Related Keywords

Japan ,Mike Mason ,Patrick Johnson ,Leigh Ann Pusey ,David Ricks ,Joe Fletcher ,David Hyman ,Leigh Ann ,Daniel Skovronsky ,States Dan Skovronsk ,Corporate Affairs ,European Society Of Cardiology Congress ,Lilly Research Labs ,New England Journal ,European Society ,Cardiology Congress ,Otoferlin Gene ,Executive Vice President ,Lilly Diabetes ,Lilly United States Dan Skovronsk ,Chief Scientific Officer ,Lilly Immunology ,Chief Medical Officer ,Ann Pusey ,Atheist Countries ,Asian Stocks To Buy ,Eli Lilly And Company ,Lilly Neuroscience ,Dan Skovronsky ,Chronic Kidney Disease ,Mike Springnether ,Senior Vice President ,Inflammatory Bowel Disease ,